![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 8, 5940-5943, February 22, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Cell Biology, University of Texas
Southwestern Medical Center, Dallas, Texas 75390
Received for publication, November 1, 2001, and in revised form, December 7, 2001
Genetic analysis of Ras signaling has unveiled
the participation of non-enzymatic accessory proteins in signal
transmission. These proteins, KSR, CNK, and Sur-8, can interact with
multiple core components of the Ras/MAP kinase cascade and may
contribute to the structural organization of this cascade. However, the
precise biochemical nature of the contribution of these proteins to Ras signaling is currently unknown. Here we show directly that CNK and KSR
are required for stimulus dependent Raf kinase activation. CNK
is required for membrane recruitment of Raf, while KSR is likely
required to couple Raf to upstream kinases. These
results demonstrate that CNK and KSR are integral components
of the cellular machinery mediating Raf activation.
The mechanism by which Ras activation leads to activation of
downstream effectors is only beginning to be understood. In the case of
Raf kinases, activation by Ras appears to involve a combination of
membrane recruitment and other association-induced activity changes
(1). Observations that artificially membrane-targeted variants of Raf1
are constitutively active independently of Ras in transient
transfection experiments, together with observations that active Ras
can recruit Raf1 to the plasma membrane, have led to the current
paradigm for Ras function. That is, Ras-GTP acts as "molecular
flypaper" ensnaring effector molecules at the plasma membrane where
they are subsequently activated by other partially characterized
membrane-associated components (2, 3). However, some recent
observations are inconsistent with this model. At least in the case of
Raf1, Ras association makes an important contribution to activation of
Raf1 kinase activity independently of membrane recruitment (4, 5). In
addition, the association of endogenous Raf1 kinases with the plasma
membrane does not always correlate with the activity of the kinase or
the mitogenic state of the cells (6). For example, Raf1, MEK1, and
ERK1/2 can be found constitutively associated with the caveolar plasma
membrane of primary human fibroblasts independently of the activation
state of these proteins. In addition, these components can be activated
in a mitogen-dependent fashion in purified caveolae (6)
strongly suggesting that the
Ras/MAP1 kinase cascade can
exist as a coherent spatially organized signal transduction machine.
Adding to the complexity, a growing number of observations have
implicated non-enzymatic accessory proteins in the regulation of the
Ras-Raf-MAP kinase cascade. These include molecules such as KSR1,
Sur-8, CNK, and MP-1. These proteins have characteristics suggestive of
roles as scaffolding and or adapter proteins (reviewed in Ref. 7).
However it is still unknown whether any of these proteins directly
participate in activation of the Raf/MAP kinase cascade, and, if so,
whether they may function to localize kinases to sites of action,
nucleate or stabilize activation complexes, enhance substrate
recognition, alter kinetics of kinase activation, and/or restrict
kinase specificity.
Genetic epistasis analysis of KSR, CNK, and Sur-8 alleles in
Drosophila or Caenorhabditis elegans places the
function of all three proteins downstream of activated Ras and upstream
of or in parallel with Raf (8-12). The direct consequence of KSR, CNK, or Sur-8 alleles on the biochemical activity of the Raf/Erk cascade has
not been examined. However, biochemical analysis of mammalian orthologs
of these genes suggest participation of these proteins in regulation of
ERK kinases (13). Sur-8 can interact with both Ras-GTP and Raf and can
facilitate formation of functional Ras/Raf complexes when all three
proteins are ectopically expressed, suggesting Sur-8 may function as an
adapter for the Ras-GTP/Raf complex (12, 14). KSR can interact directly
with MEK and will inhibit ERK activation when overexpressed (15, 16).
However, low level expression of KSR can facilitate MEK and ERK
activation (17). These results, coupled with the observation that
overexpressed KSR can associate with Raf in a Ras-dependent
manner have led to the hypothesis that KSR may function as an adapter
protein to facilitate Raf-MEK and/or MEK-ERK kinase-substrate
interactions (18, 19). MP1 was identified in two-hybrid screen as a
MEK1-interacting protein and can simultaneously interact with both MEK1
and ERK1. Like KSR1, MP1 can inhibit or potentiate ERK activation
depending upon levels of MP1 expression and may modulate the MEK-ERK
interaction (20).
The stoichiometry of scaffolds relative to the components they can
assemble is likely to be strictly regulated. A surfeit of scaffold may
disperse the very components that must function together to mediate a
signal transduction cascade (21, 22). Therefore ectopic expression
analysis is less than ideal for characterization of potential
scaffold/adapter proteins and may be partially responsible for
paradoxical or apparently contradictory observations of protein function (13, 22, 23). For this reason, we sought a biochemically tractable model system in which to examine the consequences of loss-of-function of scaffolding proteins on regulation of the MAP
kinase cascade.
Recently, it has been demonstrated that the Drosophila
Schneider L2 cell line (S2) responds to insulin by activation of
endogenous ERK-A (ERK2 ortholog) through activation of the canonical
receptor-coupled Ras-Raf kinase cascade, just as has been previously
characterized in mammalian cells. Together with the observation that S2
cells are extremely amenable to double-stranded RNA-mediated
interference of gene expression (RNAi), thus allowing
analysis of loss-of-function phenotypes, these cells become an ideal
model system in which to characterize the contribution of accessory
proteins to the regulation of the Ras/MAP kinase cascade (24).
To directly assess the contribution of putative scaffold/adaptor
proteins to regulation of the Ras/MAP kinase cascade, we examined the
consequences of knocking down the expression of KSR1, CNK, Sur-8, and
MP1 on stimulus-dependent activation of this cascade. We
show here that both CNK and KSR are required for activation of ERK in
response to insulin and phorbol ester. We demonstrate that the
molecular level at which both CNK and KSR1 impact this cascade is
directly at the Raf serine/threonine kinase. CNK and KSR are both
required for activation of Raf but not Ras. Remarkably, CNK rather than
Ras is primarily responsible for compartmentalization of a pool of Raf
kinase at the plasma membrane. These results demonstrate that CNK and
KSR are integral components of the cellular machinery that mediates Raf
activation in response to active Ras.
Materials--
Double-stranded RNA (dsRNA) was prepared and used
according to Clemens et al. (24). Schneider L2 (S2) cells
were cultured in Drosophila serum-free media (Invitrogen)
supplemented with 16.5 mM L-glutamine
(Invitrogen) and 50 µg/ml gentamicin (Sigma). Total RNA was prepared
using the High Pure RNA Isolation Kit (Roche Molecular Diagnostics).
Reverse transcriptase-PCR was performed using Superscript First
Strand Synthesis system for reverse transcriptase-PCR (Invitrogen).
Antibodies against phospho-ERK and total ERK were purchased from Sigma
(M5670, M8159). Anti-phospho-Akt antibody was from Cell Signaling
(9271). Antibody against Drosophila total Akt was a generous
gift from Brian Hemmings. Draf and Dras antibodies were generous gifts
from Deborah Morrison and Helmut Kramer, respectively. Antibodies
against MEK1/2 and phospho-MEK1/2 were from Cell Signaling (9122) and
Sigma (no. I27-67).
Raf Kinase Assay--
S2 cells were stimulated with 10 µg/ml
human recombinant insulin for 0, 5, 10 min and immediately lysed in a
modified RIPA buffer (20 mM Tris, pH 8.0, 137 mM NaCl, 10% glycerol, 1% Triton X-100, 0.5% sodium
deoxycholate, 2 mM EDTA, 5 mM sodium
orthovanadate, 25 mM Cell Fractionation--
S2 cells were resuspended in
homogenization buffer (20 mM Tris, pH 7.5, 0.25 M sucrose, 5 mM sodium orthovanadate, 25 mM To assess the contribution of putative scaffolding/adaptor
proteins to ERK activation, S2 cells were treated with dsRNAs targeted to KSR-1, CNK, the Drosophila ortholog of Sur-8
(GenBankTM accession AE003717), and the
Drosophila ortholog of MP1 (CG5110 accession AAF53620). As
reported by Clemens et al. (24), addition of double-stranded
RNA to the culture media resulted in a robust and specific reduction in
transcript levels for the targeted genes (Fig.
1). Targeting Sur-8 or MP1 had no
detectable effect on activation of ERK (not shown), however, we found
that both CNK and KSR are required for activation of ERK in response to
insulin (Fig. 2A). AKT
activation was unaffected by loss of KSR or CNK, demonstrating that
insulin signaling was not generally inhibited (Fig. 2B). As
expected, dsRNA directed against Ras also blocked ERK activation (Fig.
2A). In contrast to KSR and CNK, down-regulation of Ras
partially reduces activation of AKT by insulin (Fig. 2B).
This is consistent with published observations suggesting a
contribution of Ras to activation of phosphatidylinositol 3-kinase (25,
26).
Genetic analysis of the developmental phenotypes induced upon
hyperactivation of ERK suggests that KSR and CNK both act at the level
of Raf or in parallel with Raf (8, 11). However, the observation that
KSR can interact with MEK and ERK suggests that this protein may
function as a linker to potentiate the MEK/ERK kinase-substrate
interaction (16, 27, 28). As with ERK, we found insulin activation of
MEK, as displayed with an anti-Ser(P)-217/221 MEK antibody, was
inhibited by KSR or CNK dsRNAs (data not shown). To examine Raf
activity, anti-dRAF immunoprecipitates were mixed with recombinant
kinase-dead human MEK1 in in vitro kinase reactions. As
shown in Fig. 3, both CNK and KSR are
required for insulin activation of Raf kinase activity.
Critical Contribution of Linker Proteins to Raf Kinase
Activation*
,
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
-glycerophosphate, 2 mM
sodium pyrophosphate). After rotation for 20 min at 4 °C, the cell
lysates were cleared by centrifugation at 17,000 × g
for 15 min. From the cleared lysates, D-Raf was immunoprecipitated with
2
of a polyclonal rabbit anti-D-Raf antibody. The immunoprecipitates
were then washed three times in RIPA buffer (137 mM NaCl),
two times in a high salt RIPA buffer (500 mM NaCl), and
finally two times in 25 mM HEPES + 10 mM
MgCl2. To the 20
of washed immunoprecipitates were added
30
of kinase reaction buffer (25 mM HEPES, pH 7.4, 10 mM MgCl2, 83 µM ATP, and 0.5 µg of recombinant His-MEK1
N1(K97M)). After incubation for 30 min at
30 °C, MEK1 phosphorylation was assayed using an antibody that specifically recognizes Ser(P)-217/221.
-glycerophosphate, 2 mM sodium
pyrophosphate, 20 mM NaF) and incubated for 15 min on ice.
The cells were then subject to nitrogen cavitation at 600 psi. Upon
release of pressure, the disrupted cells were centrifuged at
17,000 × g for 5 min. The supernatant was then
centrifuged for 1 h at 100,000 × g. P100
designates the pelleted material, whereas S100 designates the soluble
supernatant. 1% of the total S100 and 10% of the total P100 fractions
from each sample were loaded for Western analysis. Signal intensities
from anti-Raf immunoblots were quantitated using an Alpha Inotech
digital imaging system together with the Flouro-Chem software package (Scimetrics).
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (38K):
[in a new window]
Fig. 1.
RNA interference of gene expression.
A, S2 cells (1 × 106) were plated in a
35-mm dish and treated with 5 µg/ml of the indicated dsRNA or left
untreated. After 72 h, RNA was isolated and analyzed by reverse
transcription-coupled PCR with the indicated transcript-specific primer
pairs. B, whole cell lysates, from cells treated with Ras or
Raf dsRNA as described above, were resolved by SDS-PAGE and
immunoblotted with the indicated antibodies.

View larger version (47K):
[in a new window]
Fig. 2.
KSR and CNK are required for insulin-induced
activation of ERK-A. Cells treated as described in the legend to
Fig. 1 were stimulated with 10 µg/ml recombinant human insulin
(Sigma) for the indicated times. Whole cell lysates were analyzed for
levels of active ERK (A) or levels of active AKT
(B) using activating phosphorylation site-specific
antibodies. Similar results were obtained in three independent
experiments.

View larger version (45K):
[in a new window]
Fig. 3.
KSR and CNK are required for insulin-mediated
activation of Raf. S2 cells were treated as in Fig. 1. Anti D-Raf
immunoprecipitates were extensively washed, then incubated with
recombinant His6-Mek1(K97M) for in vitro kinase
reactions. Dually phosphorylated MEK1(K97M) was detected using
anti-active MEK1 antibody. Relative substrate and D-Raf amounts present
in the in vitro reactions are shown. Levels of phospho-ERK
and Ras proteins present in the whole cell lysates from the same
experiment are also shown. Similar results were obtained in two
independent experiments.
The observation that Ras, but not CNK or KSR, contributes to activation
of AKT in response to insulin suggests that insulin activation of Ras
is not affected by down-regulation of CNK or KSR. This places the
activity of KSR and CNK squarely at the level of Raf activation.
Overexpressed CNK is enriched at sites of cell/cell contact
potentially via PH domain-mediated interaction with
phosphatidylinositol phosphates. CNK can also associate with Raf when
overexpressed in cells (11). These observations hint that CNK may
contribute to plasma membrane compartmentalization of Raf. Multiple
studies suggest Raf must be targeted to the plasma membrane prior to
activation (13). Consistent with observations in mammalian cell culture systems, we find Raf protein both in the membrane particulate fraction
(P100) and the soluble fraction (S100) of mechanically disrupted S2
cells. Down-regulation of CNK resulted in a dramatic reduction of Raf
protein in the P100 fraction independently of insulin stimulation (Fig.
4). Surprisingly, the presence of Raf in
the P100 fraction is more dependent upon CNK than Ras. This result
strongly suggests that the contribution of CNK to Raf activation is at
least in part through appropriate compartmentalization of Raf proteins
to the site of activation. In contrast, down-regulation of KSR had no
detectable effect on Raf compartmentalization (data not shown).
|
To further elaborate a general requirement of KSR and CNK to mediate
Raf activation, we screened for additional ERK stimuli in S2 cells. We
found that ERK is activated in response to 1 µM phorbol
12-myristate 13-acetate (PMA). A body of literature suggests that PMA
activation of ERK is mediated by PKC and Raf independently of Ras
(29-32). The majority of these studies employed dominant inhibitory
Ras variants to exclude a role for Ras activity. However, recent
studies using neutralizing Ras antibodies demonstrate that Ras is
required for PMA activation of ERK (33, 34). Consistent with these
later studies, we found that down-regulation of Ras blocks PMA
activation of ERK (Fig. 5). Similarly,
CNK and KSR are required for PMA-induced activation of ERK (Fig.
5).
|
In summary, we have provided the first direct biochemical evidence that CNK and KSR are integral components of the cellular machinery required for Raf activation. Transfected epitope-tagged CNK, and a related mammalian protein MAGUIN (MAGUK-interacting protein), can both interact with Raf in cells suggesting that native CNK and Raf form complexes (11, 35). Both transfected CNK and MAGUIN partially localize to plasma membrane compartments (11, 35). These observations lead to the hypothesis that CNK may participate in regulating compartmentalization of Raf in cells. However, expression of MAGUIN was not sufficient to recruit Raf1 to the plasma membrane (35). Therefore, there have been no direct observations supporting this hypothesis. Here, we have directly shown that inhibition of native CNK expression blocks native Raf activation, and prevents compartmentalization of Raf at the plasma membrane, suggesting the biochemical contribution of CNK to Raf activation is at least partially due to facilitation of appropriate cellular localization.
KSR contains a putative serine/threonine kinase domain (8). One group
has reported that immunoprecipitated KSR can phosphorylate Raf in
vitro, which is compelling evidence for a biochemical relationship between Raf and KSR (36). On the other hand, other groups find no
evidence for an intrinsic kinase activity of KSR and contest the
classification of this protein as a kinase (23, 37, 38). Several
reports do show that KSR immunoprecipitates from cells are tightly
associated with kinases that can phosphorylate KSR itself, but these
KSR-associated kinases reportedly do not utilize Raf1 as a substrate
in vitro (23, 38). Our direct biochemical observation of the
requirement of KSR for Raf activation is consistent with either the
possibility that KSR is indeed a Raf kinase, or that it is a linker
protein required to couple Raf to the upstream kinases that are
responsible for activating phosphorylation events on Raf. Unlike CNK,
KSR does not appear to be required to compartmentalize Raf at the
plasma membrane (data not shown). Studies are currently underway to
employ the system described here to identify critical kinases
responsible for Raf activation.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Deborah Morrison, Brian Hemmings, and Helmut Kramer for generous gifts of antibodies. We thank Bing Xu and Melanie Cobb for help and advice with Raf kinase assays.
| |
FOOTNOTES |
|---|
* This work was supported by Grant CA71443 from the National Cancer Institute and Grant I-1414 from the Welch Foundation.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Both authors contributed equally to this work.
§ To whom correspondence should be addressed: Dept. of Cell Biology, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-2861; Fax: 214-648-8694; E-mail: michael.white@utsouthwestern.edu.
Published, JBC Papers in Press, December 7, 2001, DOI 10.1074/jbc.M110498200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: MAP, mitogen-activated protein; ERK, extracellular-regulated kinase; MEK, MAP kinase/ERK kinase; ds, double-stranded; RIPA, radioimmune precipitation buffer; PMA, phorbol 12-myristate 13-acetate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Campbell, S. L., Khosravi-Far, R., Rossman, K. L., Clark, G. J., and Der, C. J. (1998) Oncogene 17, 1395-1413[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Stokoe, D.,
Macdonald, S. G.,
Cadwallader, K.,
Symons, M.,
and Hancock, J. F.
(1994)
Science
264,
1463-1467 |
| 3. | Leevers, S. J., Paterson, H. F., and Marshall, C. J. (1994) Nature 369, 411-414[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Mineo, C.,
Anderson, R. G.,
and White, M. A.
(1997)
J. Biol. Chem.
272,
10345-10348 |
| 5. |
Inouye, K.,
Mizutani, S.,
Koide, H.,
and Kaziro, Y.
(2000)
J. Biol. Chem.
275,
3737-3740 |
| 6. |
Liu, P.,
Ying, Y.,
and Anderson, R. G.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
13666-13670 |
| 7. | Sternberg, P. W., and Alberola-Ila, J. (1998) Cell 95, 447-450[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Therrien, M., Chang, H. C., Solomon, N. M., Karim, F. D., Wassarman, D. A., and Rubin, G. M. (1995) Cell 83, 879-888[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Sundaram, M., and Han, M. (1995) Cell 83, 889-901[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Kornfeld, K., Hom, D. B., and Horvitz, H. R. (1995) Cell 83, 903-913[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Therrien, M., Wong, A. M., and Rubin, G. M. (1998) Cell 95, 343-353[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Sieburth, D. S., Sun, Q., and Han, M. (1998) Cell 94, 119-130[CrossRef][Medline] [Order article via Infotrieve] |
| 13. | Kolch, W. (2000) Biochem. J. 351 Pt 2, 289-305 |
| 14. |
Li, W.,
Han, M.,
and Guan, K. L.
(2000)
Genes Dev.
14,
895-900 |
| 15. |
Joneson, T.,
Fulton, J. A.,
Volle, D. J.,
Chaika, O. V.,
Bar-Sagi, D.,
and Lewis, R. E.
(1998)
J. Biol. Chem.
273,
7743-7748 |
| 16. | Denouel-Galy, A., Douville, E. M., Warne, P. H., Papin, C., Laugier, D., Calothy, G., Downward, J., and Eychene, A. (1998) Curr. Biol. 8, 46-55[CrossRef][Medline] [Order article via Infotrieve] |
| 17. |
Therrien, M.,
Michaud, N. R.,
Rubin, G. M.,
and Morrison, D. K.
(1996)
Genes Dev.
10,
2684-2695 |
| 18. |
Michaud, N. R.,
Therrien, M.,
Cacace, A.,
Edsall, L. C.,
Spiegel, S.,
Rubin, G. M.,
and Morrison, D. K.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
12792-12796 |
| 19. | Sugimoto, T., Stewart, S., Han, M., and Guan, K. L. (1998) EMBO J. 17, 1717-1727[CrossRef][Medline] [Order article via Infotrieve] |
| 20. |
Schaeffer, H. J.,
Catling, A. D.,
Eblen, S. T.,
Collier, L. S.,
Krauss, A.,
and Weber, M. J.
(1998)
Science
281,
1668-1671 |
| 21. |
Levchenko, A.,
Bruck, J.,
and Sternberg, P. W.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
5818-5823 |
| 22. | Burack, W. R., and Shaw, A. S. (2000) Curr. Opin. Cell Biol. 12, 211-216[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Morrison, D. K. (2001) J. Cell Sci. 114, 1609-1612[Abstract] |
| 24. |
Clemens, J. C.,
Worby, C. A.,
Simonson-Leff, N.,
Muda, M.,
Maehama, T.,
Hemmings, B. A.,
and Dixon, J. E.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
6499-6503 |
| 25. | Marshall, C. J. (1996) Curr. Opin. Cell Biol. 8, 197-204[CrossRef][Medline] [Order article via Infotrieve] |
| 26. | Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. (1994) Nature 370, 527-532[CrossRef][Medline] [Order article via Infotrieve] |
| 27. | Yu, W., Fantl, W. J., Harrowe, G., and Williams, L. T. (1998) Curr. Biol. 8, 56-64[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Cacace, A. M.,
Michaud, N. R.,
Therrien, M.,
Mathes, K.,
Copeland, T.,
Rubin, G. M.,
and Morrison, D. K.
(1999)
Mol. Cell. Biol.
19,
229-240 |
| 29. |
Ueda, Y.,
Hirai, S.,
Osada, S.,
Suzuki, A.,
Mizuno, K.,
and Ohno, S.
(1996)
J. Biol. Chem.
271,
23512-23519 |
| 30. |
van Biesen, T.,
Hawes, B. E.,
Raymond, J. R.,
Luttrell, L. M.,
Koch, W. J.,
and Lefkowitz, R. J.
(1996)
J. Biol. Chem.
271,
1266-1269 |
| 31. |
Hawes, B. E.,
van Biesen, T.,
Koch, W. J.,
Luttrell, L. M.,
and Lefkowitz, R. J.
(1995)
J. Biol. Chem.
270,
17148-17153 |
| 32. | de Vries-Smits, A. M., Burgering, B. M., Leevers, S. J., Marshall, C. J., and Bos, J. L. (1992) Nature 357, 602-604[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Marais, R.,
Light, Y.,
Mason, C.,
Paterson, H.,
Olson, M. F.,
and Marshall, C. J.
(1998)
Science
280,
109-112 |
| 34. |
Chiloeches, A.,
Paterson, H. F.,
Marais, R.,
Clerk, A.,
Marshall, C. J.,
and Sugden, P. H.
(1999)
J. Biol. Chem.
274,
19762-19770 |
| 35. | Yao, I., Ohtsuka, T., Kawabe, H., Matsuura, Y., Takai, Y., and Hata, Y. (2000) Biochem. Biophys. Res. Commun. 270, 538-542[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Xing, H. R.,
and Kolesnick, R.
(2001)
J. Biol. Chem.
276,
9733-9741 |
| 37. |
Muller, J.,
Cacace, A. M.,
Lyons, W. E.,
McGill, C. B.,
and Morrison, D. K.
(2000)
Mol. Cell. Biol.
20,
5529-5539 |
| 38. | Muller, J., S., O., Copeland, T., Piwnica-Worms, H., and Morrison, D. K. (2001) Mol. Cell 8, 983-993[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
C. Chen, R. E. Lewis, and M. A. White IMP Modulates KSR1-dependent Multivalent Complex Formation to Specify ERK1/2 Pathway Activation and Response Thresholds J. Biol. Chem., May 9, 2008; 283(19): 12789 - 12796. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Roignant, S. Hamel, F. Janody, and J. E. Treisman The novel SAM domain protein Aveugle is required for Raf activation in the Drosophila EGF receptor signaling pathway. Genes & Dev., April 1, 2006; 20(7): 795 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Douziech, M. Sahmi, G. Laberge, and M. Therrien A KSR/CNK complex mediated by HYP, a novel SAM domain-containing protein, regulates RAS-dependent RAF activation in Drosophila. Genes & Dev., April 1, 2006; 20(7): 807 - 819. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Rocheleau, A. Ronnlund, S. Tuck, and M. V. Sundaram Caenorhabditis elegans CNK-1 promotes Raf activation but is not essential for Ras/Raf signaling PNAS, August 16, 2005; 102(33): 11757 - 11762. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ziogas, K. Moelling, and G. Radziwill CNK1 Is a Scaffold Protein That Regulates Src-mediated Raf-1 Activation J. Biol. Chem., June 24, 2005; 280(25): 24205 - 24211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salerno, D. Palmieri, A. Bouadis, D. Halverson, and P. S. Steeg Nm23-H1 Metastasis Suppressor Expression Level Influences the Binding Properties, Stability, and Function of the Kinase Suppressor of Ras1 (KSR1) Erk Scaffold in Breast Carcinoma Cells Mol. Cell. Biol., February 15, 2005; 25(4): 1379 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Copp, S. Wiley, M. W. Ward, and P. van der Geer Hypertonic shock inhibits growth factor receptor signaling, induces caspase-3 activation, and causes reversible fragmentation of the mitochondrial network Am J Physiol Cell Physiol, February 1, 2005; 288(2): C403 - C415. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rabizadeh, R. J. Xavier, K. Ishiguro, J. Bernabeortiz, M. Lopez-Ilasaca, A. Khokhlatchev, P. Mollahan, G. P. Pfeifer, J. Avruch, and B. Seed The Scaffold Protein CNK1 Interacts with the Tumor Suppressor RASSF1A and Augments RASSF1A-induced Cell Death J. Biol. Chem., July 9, 2004; 279(28): 29247 - 29254. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mallon, L. Feldberg, S. Kim, K. Collins, D. Wojciechowicz, C. Kohler, D. Kovacs, C. Discafani, N. Zhang, B. Wu, et al. Identification of 4-anilino-3-quinolinecarbonitrile inhibitors of mitogen-activated protein/extracellular signal-regulated kinase 1 kinase Mol. Cancer Ther., June 1, 2004; 3(6): 755 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Kortum and R. E. Lewis The Molecular Scaffold KSR1 Regulates the Proliferative and Oncogenic Potential of Cells Mol. Cell. Biol., May 15, 2004; 24(10): 4407 - 4416. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Kho, Z. Wang, L. Zhuang, Y. Li, J.-L. Chew, H.-H. Ng, E. T. Liu, and Q. Yu p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis J. Biol. Chem., May 14, 2004; 279(20): 21183 - 21192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Jaffe, P. Aspenstrom, and A. Hall Human CNK1 Acts as a Scaffold Protein, Linking Rho and Ras Signal Transduction Pathways Mol. Cell. Biol., February 15, 2004; 24(4): 1736 - 1746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-z. Zhang, M. Sinha, B. A. Luxon, and X.-j. Yu Survival Strategy of Obligately Intracellular Ehrlichia chaffeensis: Novel Modulation of Immune Response and Host Cell Cycles Infect. Immun., January 1, 2004; 72(1): 498 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. LANIGAN, A. LIU, Y. Z. HUANG, L. MEI, B. MARGOLIS, and K.-L. GUAN Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf FASEB J, November 1, 2003; 17(14): 2048 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. J. Janssen, P. N. Kim, J. W. Mier, and D. K. Morrison Overexpression of Kinase Suppressor of Ras Upregulates the High-Molecular-Weight Tropomyosin Isoforms in ras-Transformed NIH 3T3 Fibroblasts Mol. Cell. Biol., March 1, 2003; 23(5): 1786 - 1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Raabe and U. R. Rapp KSR--A Regulator and Scaffold Protein of the MAPK Pathway Sci. Signal., June 11, 2002; 2002(136): pe28 - pe28. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |